Related Experiment Video
Updated: Aug 15, 2026
Isolation of Human Atrial Myocytes for Simultaneous Measurements of Ca2+ Transients and Membrane Currents
Published on: July 3, 2013
Acquired vs innate multidrug resistance and the effect of calcium channel blockers
Abstract:
Innate drug resistance as well as acquired multidrug resistance are directly related to ineffectiveness and failure of the cancer chemotherapy. The mechanisms of such resistance, especially those of innate resistance, have not been fully elucidated. We have established vincristine (VCR)- and Adriamycin (ADM)-resistant sublines of human myelogenous leukemia K562 by continuous drug exposure. These resistant sublines contained double minute chromosomes and express a glycoprotein with a 180,000 dalton M.W. Analysis of VCR and ADM sensitivities of several isolated clones from these resistant sublines revealed a tight relationship between these two resistant mechanisms. However, ADM resistant sublines are always highly resistant to VCR, but VCR resistant sublines are not necessarily highly resistant to ADM, suggesting the presence different mechanisms of ADM and VCR resistance. Calcium channel blockers inhibit the drug efflux in these resistant tumor cells, thereby overcoming of drug resistance. Greater potentition was observed with antitumor agents to which VCR- and ADM-resistant cells were highly cross-resistant. Calcium channel blockers always show higher potentiation with VCR than ADM, and the clones with greater resistance to VCR generally accumulated less VCR and generally possessed a higher rate of VCR efflux. These results might indicate that a major mechanism of VCR resistance could be a defficiency in drug transport and this mechanism can be reversed by calcium channel blockers, while the ADM resistance mechanisms are partly related to drug efflux and only this mechanism of the ADM resistance can be modulated by calcium channel blockers. Calcium channel blockers also potentiate the drug effects, especially that of vinca alkaloids, in innately resistant tumors cells, indicating that such innate resistant cells also share a similar resistance mechanism to that observed in acquired drug resistance. From these results, the mechanisms of acquired and innate drug resistance are discussed.
Insights
This study explores cancer chemotherapy resistance, finding calcium channel blockers can overcome drug resistance in leukemia cells by affecting drug transport and efflux, potentially improving treatment outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Multidrug resistance (MDR) in cancer chemotherapy leads to treatment failure.
- Mechanisms of innate drug resistance remain incompletely understood.
- Established drug-resistant leukemia cell lines to study resistance.
Purpose of the Study:
- Investigate mechanisms of acquired and innate multidrug resistance.
- Determine the role of drug efflux and transport in resistance.
- Evaluate the efficacy of calcium channel blockers in overcoming resistance.
Main Methods:
- Developed vincristine (VCR) and Adriamycin (ADM)-resistant human myelogenous leukemia K562 sublines.
- Analyzed drug sensitivities and characterized resistant cell properties.
- Assessed the effect of calcium channel blockers on drug accumulation and efflux.
Main Results:
- Resistant sublines exhibited double minute chromosomes and expressed a 180 kDa glycoprotein.
- ADM resistance correlated with VCR resistance, but not vice versa, suggesting distinct mechanisms.
- Calcium channel blockers inhibited drug efflux, potentiating VCR and ADM efficacy, particularly in VCR-resistant cells.
Conclusions:
- VCR resistance may stem from deficient drug transport, reversible by calcium channel blockers.
- ADM resistance involves drug efflux, partially modulated by calcium channel blockers.
- Innate drug resistance shares mechanisms with acquired resistance, suggesting calcium channel blockers as a potential therapeutic strategy.
More Related Videos
07:42Contractions of Human-iPSC-derived Cardiomyocyte Syncytia Measured with a Ca-sensitive Fluorescent Dye in Temperature-controlled 384-well Plates
Published on: October 18, 2018
10:01High-Throughput Optical Controlling and Recording Calcium Signal in iPSC-Derived Cardiomyocytes for Toxicity Testing and Phenotypic Drug Screening
Published on: March 31, 2022
Related Concept Videos
01:18Antihypertensive Drugs: Action of Calcium Channel Blockers
01:22Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
01:24Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
01:20Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
01:17Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...